3DSecret
3DSecret provides tools to analyze and predict metastatic breast cancer behavior from individual circulating tumor cells. The consortium builds microfluidic platforms—including the 3Dsecret-chip—that isolate CTCs, culture them into reproducible 3D spheroids, and combine SERS metabolomics with genomic and transcriptomic profiling. Their approach integrates microfluidics, nanotechnology, genomics, and artificial intelligence to decode stochastic metastatic patterns at single-cell resolution. The technology is aimed at cancer researchers and biomedical labs for preclinical research and diagnostic-method development.
3DSecret
3DSecret provides tools to analyze and predict metastatic breast cancer behavior from individual circulating tumor cells. The consortium builds microfluidic platforms—including the 3Dsecret-chip—that isolate CTCs, culture them into reproducible 3D spheroids, and combine SERS metabolomics with genomic and transcriptomic profiling. Their approach integrates microfluidics, nanotechnology, genomics, and artificial intelligence to decode stochastic metastatic patterns at single-cell resolution. The technology is aimed at cancer researchers and biomedical labs for preclinical research and diagnostic-method development.